Assignee
PHARMACOSMOS HOLDING AS
DK·26 granted patents·12 pending applications·115 citations·filing 1999–2025
Top patents by PatentIndex Score
38 records- 0195US11851504B2Stable iron oligosaccharide compoundPHARMACOSMOS HOLDING AS·Filed 2021·Granted Dec 26, 2023·2 cites·26 claims
- 0293US12364697B2G1T38 superior dosage regimesPHARMACOSMOS HOLDING AS·Filed 2022·Granted Jul 22, 2025·4 cites·18 claims
- 0393US12264135B2Synthesis of 1,4-diazaspiro[5.5]undecan-3-onePHARMACOSMOS HOLDING AS·Filed 2023·Granted Apr 1, 2025·3 cites·18 claims
- 0493US9439969B2Stable iron oligosaccharide compoundPHARMACOSMOS HOLDING AS·Filed 2014·Granted Sep 13, 2016·16 cites·2 claims
- 0592US11806329B2Treating iron deficiency with ferric carboxymaltosePHARMACOSMOS HOLDING AS·Filed 2021·Granted Nov 7, 2023·3 cites·34 claims
- 0692US11111261B2Iron complex compounds for therapeutic usePHARMACOSMOS HOLDING AS·Filed 2019·Granted Sep 7, 2021·2 cites·25 claims
- 0792US11020369B2Treating iron deficiency with ferric carboxymaltosePHARMACOSMOS HOLDING AS·Filed 2020·Granted Jun 1, 2021·5 cites·22 claims
- 0890US10414831B2Stable iron oligosaccharide compoundPHARMACOSMOS HOLDING AS·Filed 2018·Granted Sep 17, 2019·6 cites·30 claims
- 0988US2024279262A1Iron complex compounds for theraputic usePHARMACOSMOS HOLDING AS·Filed 2024·Application pending·0 cites
- 1088US2025026864A1Stable iron oligosaccharide compoundPHARMACOSMOS HOLDING AS·Filed 2024·Application pending·0 cites
- 1187US12030962B2Stable iron oligosaccharide compoundPHARMACOSMOS HOLDING AS·Filed 2020·Granted Jul 9, 2024·1 cites·10 claims
- 1287US2026091015A1Treating iron deficiency with ferric carboxymaltosePHARMACOSMOS HOLDING AS·Filed 2025·Application pending·0 cites
- 1386US2025101030A1Morphic forms of trilaciclib and methods of manufacture thereofPHARMACOSMOS HOLDING AS·Filed 2024·Application pending·0 cites
- 1485US11633489B2Iron carbohydrate complex for treatment of iron deficiency of a fetus or an infantPHARMACOSMOS HOLDING AS·Filed 2021·Granted Apr 25, 2023·1 cites·22 claims
- 1585US11471483B2Iron carbohydrate complex for treatment of restless leg syndrome (RLS)PHARMACOSMOS HOLDING AS·Filed 2021·Granted Oct 18, 2022·1 cites·20 claims
- 1682US12534472B2Morphic forms of trilaciclib and methods of manufacture thereofPHARMACOSMOS HOLDING AS·Filed 2025·Granted Jan 27, 2026·0 cites·14 claims
- 1782US12303486B2Treating iron deficiency with ferric carboxymaltosePHARMACOSMOS HOLDING AS·Filed 2023·Granted May 20, 2025·0 cites·29 claims
- 1882US10865255B2Stable iron oligosaccharide compoundPHARMACOSMOS HOLDING AS·Filed 2016·Granted Dec 15, 2020·1 cites·28 claims
- 1981US12497404B2Morphic forms of trilaciclib and methods of manufacture thereofPHARMACOSMOS HOLDING AS·Filed 2025·Granted Dec 16, 2025·0 cites·11 claims
- 2081US12479855B2Morphic forms of trilaciclib and methods of manufacture thereofPHARMACOSMOS HOLDING AS·Filed 2025·Granted Nov 25, 2025·0 cites·13 claims
- 2181US12295934B2Treating iron deficiency with ferric carboxymaltosePHARMACOSMOS HOLDING AS·Filed 2023·Granted May 13, 2025·0 cites·60 claims
- 2281US11040059B2Treatment or prevention of anaemia in pregnant non-human mammalsPHARMACOSMOS HOLDING AS·Filed 2015·Granted Jun 22, 2021·2 cites·17 claims
- 2377US12565502B2Substituted 1′,2′-dihydro-3′h-spiro[cyclohexane-1,4′-pyrimido[5′,4′:4,5]pyrrolo[2,1-c] [1,2,4]triazin]-3′-ones as cyclin-dependent kinase inhibitorsPHARMACOSMOS HOLDING AS·Filed 2025·Granted Mar 3, 2026·0 cites·27 claims
- 2477US12312360B2Substituted 1′,2′-dihydro-3′H-spiro[cyclohexane-1,4′-pyrimido[5′,4′:4,5]pyrrolo[2,1-c][1,2,4]triazin]-3′-ones as cyclin-dependent kinase inhibitorsPHARMACOSMOS HOLDING AS·Filed 2023·Granted May 27, 2025·0 cites·28 claims
- 2577US2022041640A1Iron complex compounds for theraputic usePHARMACOSMOS HOLDING AS·Filed 2021·Application pending·0 cites
- 2677US2025304592A1Morphic forms of g1t38 and methods of manufacture thereofPHARMACOSMOS HOLDING AS·Filed 2024·Application pending·0 cites
- 2776US11040064B2Iron carbohydrate complex for treatment of restless leg syndrome (RLS)PHARMACOSMOS HOLDING AS·Filed 2016·Granted Jun 22, 2021·1 cites·19 claims
- 2876US2026014160A1G1t38 superior dosage regimesPHARMACOSMOS HOLDING AS·Filed 2025·Application pending·0 cites
- 2974US6977249B1Process for producing an iron-dextran compound, iron-dextran compound produced according to said process, pharmaceutical composition for prophylaxis or treatment of iron-deficiency and use of said compound for the preparation of parenterally administrable pharmaceutical compositionPHARMACOSMOS HOLDING AS·Filed 1999·Granted Dec 20, 2005·35 cites·28 claims
- 3072US10960081B2Iron carbohydrate complex for treatment of iron deficiency of a fetus or an infantPHARMACOSMOS HOLDING AS·Filed 2016·Granted Mar 30, 2021·1 cites·14 claims
- 3170US6291440B1Iron-dextran compound for use as a component in a therapeutical composition for prophylaxis or treatment of iron-deficiencyPHARMACOSMOS HOLDING AS·Filed 1999·Granted Sep 18, 2001·30 cites·18 claims
- 3269US12527798B2Preservation of immune response during chemotherapy regimensPHARMACOSMOS HOLDING AS·Filed 2022·Granted Jan 20, 2026·0 cites·19 claims
- 3369US11484025B2Cryoprotecting agent, cryoprotecting and cryopreserved compositions, uses thereof, and methods of cryopreservationPHARMACOSMOS HOLDING AS·Filed 2013·Granted Nov 1, 2022·1 cites·31 claims
- 3458US2021369763A1Treatment or prevention of anaemia in pregnant non-human mammalsPHARMACOSMOS HOLDING AS·Filed 2021·Application pending·0 cites
- 3557US2023097342A1Cryoprotecting agent, cryoprotecting and cryopreserved compositions, uses thereof, and methods of cryopreservationPHARMACOSMOS HOLDING AS·Filed 2022·Application pending·0 cites
- 3650US2003191090A1Iron dextrin compounds for the treatment of iron deficiency anaemiaPHARMACOSMOS HOLDING AS·Filed 2003·Application pending·0 cites
- 3748US2022062331A1Treating iron deficiency in subjects at risk of cardiovascular adverse events and iron for the management of atrial fibrillationPHARMACOSMOS HOLDING AS·Filed 2020·Application pending·0 cites
- 3847US2003083310A1Process for producing an iron-dextran compound, iron-dextran compound produced according to said process, pharmaceutical composition for prophylaxis or treatment of iron-deficiency and use of said compound for the preparation of a parenterally administrable pharmaceutical compositionPHARMACOSMOS HOLDING AS·Filed 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when PHARMACOSMOS HOLDING AS files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →